Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.17/1481
Título: Low Dose Thalidomide for Treatment of Resistant Discoid Lupus Erythematosus. A Case Report
Autor: Campos, S
Ponte, P
Lestre, S
Palavras-chave: Talidomida
Terapêutica
Lúpus Eritematoso Discoide
Data: 2013
Editora: Serviço de Dermatologia do Hospital dos Capuchos, Centro Hospitalar de Lisboa Central, EPE; Serviço de Dermatologia do Hospital de Torres Vedras
Citação: IN: 22nd Congress of the European Academy of Dermatology and Venereology; 2013, 2 a 6 Out. Istambul, Turquia
Resumo: Discoid lupus erythematosus (DLE) is a chronic, indolent, disfiguring disease that is characterized by scaly, erythematous, disk-shaped patches and plaques followed by atrophy, scarring and depigmentation. In a small number of patients, it is refractory to standard therapies. In several studies, thalidomide has been reported to be an effective treatment in those cases. The most fearful side effects are teratogenicity and neuropathy. Adequate counseling and vigilance must be given to the patients. We report a 45-year-old Portuguese woman who presented with a 20-year history of severe facial and scalp DLE confirmed by histopathology. For several years, it failed to respond to several therapies, including topical, intralesional and oral corticosteroids, hydroxychloroquine, methotrexate, azathioprine and topical tacrolimus. Thalidomide was initiated at a dosage of 50mg/day and the skin lesions had improved dramatically after three weeks with complete clinical remission. Two months later, the dose was reduced to 50mg, five days per week without disease rebound. The patient´s concomitant medications during the treatment included sunscreen, hydroxycholoroquine, enoxaparin and aspirin to prevent thromboembolic events. Pregnancy testing, routine laboratory and electrocardiography were performed at regular intervals for safety monitoring and the results were within normal limits. Only minor side effects as nausea, constipation and somnolence were noted, however, they improved with dose reduction. Our data confirm that thalidomide therapy is an alternative or adjunctive treatment for patients with severe, chronic DLE that is refractory to standard therapies. In this patient, low-dose thalidomide was an effective treatment with minimal side effects.
URI: http://hdl.handle.net/10400.17/1481
Aparece nas colecções:DER - Comunicações e Conferências

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
LES e talidomida caso clinico EADV turquia.pdf536,54 kBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.